Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. LNSR

Market Cap: $93.34M

LI

LENSAR Inc

LNSR
NASDAQUSD
Purchase LNSR
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin47.96%
EBITDA Margin59.05%
EBIT Margin52.92%
Pre-tax Margin57.57%
Net Profit Margin57.57%
Earnings Yield37.13%
Valuation Multiples
Price / Book6.27
Price / Sales1.55
Price / Earnings5.98
PEG0.02
Forward PEG-1.87
EV / Sales1.36
EV / EBITDA2.31
EV / Operating Cash Flow-11.27
EV / Free Cash Flow-11.21
Price / Free Cash Flow-12.74
Price / Operating Cash Flow-12.81
Cash Flow & Capital
Free Cash Flow / Share-$0.6
Operating Cash Flow / Share-$0.59
Free Cash Flow Yield-7.85%
Capex / Revenue0.06%
Capex / Operating Cash Flow-0.48%
Capex / Depreciation0.01
Stock Compensation / Revenue3.43%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio2.39
Quick Ratio1.13
Cash Ratio0.69
Debt / Assets0.03
Debt / Capital0.14
Debt / Equity0.16
Long-Term Debt / Capital0.00
Debt / Market Cap0.00%
Net Debt / EBITDA-0.31
Solvency Ratio0.70
Financial Leverage4.67
Efficiency & Working Capital
Asset Turnover0.87
Fixed Asset Turnover4.06
Inventory Turnover1.26
Receivables Turnover9.03
Payables Turnover2.80
Days Sales Outstanding40.4
Days Inventory Outstanding289.46
Days Payables Outstanding130.27
Operating Cycle329.86
Cash Conversion Cycle199.59
Working Capital Turnover2.32
Returns & Quality
Return on Equity103.80%
Return on Assets49.88%
Return on Invested Capital-16.02%
ROCE-16.28%
Return on Tangible Assets53.52%
Operating Return on Assets-11.97%
Income Quality-0.42
Tax Burden1.00
Interest Burden1.09
Balance Sheet & Intrinsic Metrics
Enterprise Value$82.16M
Invested Capital$46.98M
Working Capital$27.39M
Tangible Asset Value$10.17M
Net Current Asset Value$-7.63M
Graham Number$8.77
Graham Net-Net-$1.92
Book Value / Share$1.21
Tangible Book Value / Share$0.83
Cash / Share$1.1
Financial Health Scores
Piotroski Score5
Altman Z-Score1.15
Revenue$60.26M
EBIT$31.89M
Market Cap$97.27M
Working Capital$27.39M
Retained Earnings$-137.71M
Total Assets$69.56M
Total Liabilities$54.65M